Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone

Mult Scler. 2003 Mar;9(2):213-4. doi: 10.1191/1352458503ms891xx.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Mitoxantrone / adverse effects*
  • Multiple Sclerosis / drug therapy*

Substances

  • Antineoplastic Agents
  • Mitoxantrone